🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A complex interaction between demographic, environmental and genetic mechan...
Status
Recruiting
Location
RI-MUHC
Start Date
2021-08-24
Trial ID
NCT05007340
RATIONALE: Monoclonal antibodies such as cetuximab, can block tumor growth ...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2005-08
Trial ID
NCT00538291
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00899535
Treatments Being Tested
RATIONALE: Erlotinib hydrochloride may stop the growth of tumor cells by bl...
Status
Terminated
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2011-01
Trial ID
NCT01192815
Treatments Being Tested
RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of...
Status
Unknown
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2008-06
Trial ID
NCT00717587
Treatments Being Tested
Williams Beuren syndrome (WBS) is a multiple malformations/intellectual dis...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT04095585
Treatments Being Tested
Lung cancer patients have a poor prognosis and only around 20 % is alive af...
Status
Completed
Location
Dept. of Oncology, Aalborg University Hospital
Start Date
2018-08-22
Trial ID
NCT03658460
Treatments Being Tested
Based on pharmacogenomics analysis technology, this topic explored its impa...
Status
Completed
Location
Tongji University
Start Date
2023-01-01
Trial ID
NCT05669391
Treatments Being Tested
RATIONALE: Nilotinib and imatinib mesylate may stop the growth of cancer ce...
Status
Completed
Location
Centro Oncologico Basilicata
Start Date
2009-02-09
Trial ID
NCT00769327
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2009-01
Trial ID
NCT00851552